Prostate Cancer Screening: UK committee Advises Against Routine Availability
Table of Contents
Prostate cancer screening should not be routinely available for the vast majority of men in the UK, according to a committee advising the Government. The UK National Screening Committee (UKNSC) has issued a draft advice stating that population screening using the prostate-specific antigen (PSA) test “is likely to cause more harm than good”.
Experts are awaiting data from a large trial launched by Prostate Cancer UK,investigating whether combining PSA with tests like rapid MRI scans could alter this recommendation. Currently, the committee will only recommend screening for men with BRCA1 and BRCA2 genetic mutations – who face a considerably higher risk – every two years between ages 45 and 61.
Health secretary Wes Streeting will consider the findings, emphasizing the need to balance earlier diagnosis and treatment with the potential harms of wider screening. Professor Sir Mike Richards, chairman of the UKNSC, explained that modelling suggests whole population screening might offer a small reduction in prostate cancer deaths, but the high rate of overdiagnosis means the harms outweigh the benefits.
Concerns about the PSA test’s reliability are central to the decision. Experts note that a high PSA level doesn’t always indicate cancer, and some men with cancer have normal results. Positive results can lead to unnecessary treatment for slow-growing or harmless tumours, potentially causing side effects like incontinence and erectile dysfunction.
The UKNSC also stated it will not recommend screening specifically for Black men – who are at double the risk – or those with a family history of the disease,citing a current lack of sufficient data. However, the committee will collaborate with the Transform trial to gather more information in these areas.
The transform trial is evaluating promising screening techniques, including PSA tests, genetic tests, and MRI scans, to determine if a combination could be effective for population-wide screening. Results are expected within two years, and the Government is providing funding for the research.
Biden Announces New Student Loan Relief Plan After Supreme Court Ruling
President Biden unveiled a new plan to provide student loan relief to millions of Americans on Tuesday,following the Supreme Court’s decision to strike down his initial forgiveness program. This revised approach aims to address the financial burdens of student debt through a different legal pathway, focusing on the Higher Education Act of 1965.
The new plan has several key components. It will involve a negotiated rulemaking process, allowing the Department of Education to work with stakeholders – including borrowers, loan servicers, and institutions – to develop a program tailored to address specific borrower needs.
Specifically, the management is exploring options to offer relief to borrowers experiencing hardship, including those facing financial difficulties, those with runaway interest, and those who originally qualified for Public Service loan Forgiveness but didn’t receive it due to past administrative failures.
“I won’t give up on delivering student debt relief for millions of Americans,” Biden stated during a press conference. “We’re going to use the authority we have to find a new path to relief.”
The Supreme Court’s 6-3 ruling in Biden v. Nebraska blocked the original plan, which would have canceled up to $20,000 in debt for Pell Grant recipients and $10,000 for other borrowers. The court argued that the administration overstepped its authority by relying on the HEROES Act, which was intended to provide relief to service members during wartime.
The new plan, built on the higher Education Act, is expected to face legal challenges as well, but the administration believes it has a stronger legal foundation.The negotiated rulemaking process is anticipated to take several months, with the goal of implementing the new program in 2024.
The White House estimates that over 40 million Americans hold federal student loan debt, totaling more than $1.7 trillion. This new initiative represents the Biden administration’s continued commitment to addressing the student debt crisis and providing economic relief to borrowers.
[https://img.resized.co/breaking-news/eyJkYXRhIjoie1widXJsXCI6XCJodHRwczpcXFwvXFxcL2ltYWdlcy5icmVha2luZ25ld3MuaWVcXFwvcHJvZFxcXC91cGxvYWRzXFxcLzIwMjVcXFwvMTFcXFwvMjMyMTM3MTJcXFwvMi43NjU3NTk0My1lMTc2MzkzMzkxODgzMy5qcGdcIixcIndpZHRoXCI6MzQ3LFwiaGVpZ2h0XCI6MTk1LFwiZGVmYXVsdFwiOlwiaHR0cHM6XFxcL1xcXC93d3cuYnJlYWtpbmduZXdzLmllXFxcL2lcXFwvYm4tbm9pbWFnZS5wbmdcIixcIm9wdGlvbnNcIjp7XCJvdXRwdXRcIjpcImF2aWZcIixcInF1YWxpdHlcIjpcIjU1XCJ9fSIsImhhc2giOiI1NWVhNjY0Mzk5NjBiMzc0NDY2ZjM2MzJhMzljM2Q4OWU1ZGNkY2NiIn0=/2-76575943-e1763933918833.jpg](https://img.resized.co/breaking-news/eyJkYXRhIjoie1widXJsXCI6XCJodHRwczpcXFwvXFxcL2ltYWdlcy5icmVha2luZ25ld3MuaWVcXFwvcHJvZFxcXC91cGxvYWRzXFxcLzIwMjVcXFwvMTFcXFwvMjMyMTM3MTJcXFwvMi43NjU3NTk0My1lMTc2MzkzMzkxODgzMy5qcGdcIixcIndpZHRoXCI6MzQ3LFwiaGVpZ2h0XCI6MTk1LFwiZGVmYXVsdFwiOlwiaHR0cHM6XFxcL1xcXC93d3cuYnJlYWtpbmduZXdzLmllXFxcL2lcXFwvYm4tbm9pbWFnZS5wbmdcIixcIm9wdGlvbnNcIjp7XCJvdXRwdXRcIjpcImF2aWZcIixcInF1YWxpdHlcIjpcIjU1XCJ9fSIsImhhc2giOiI1NWVhNjY0Mzk5NjBiMzc0NDY2ZjM2MzJhMzljM2Q4OWU1ZGNkY
Calls Grow for Prostate Cancer Screening After High-Profile Diagnoses
Recent prostate cancer diagnoses among public figures, including actor Stephen Fry and comedian Bill Turnbull (who sadly passed away in 2022), have fueled renewed calls for improved and potentially mandatory screening for men. This push gained further momentum with news of former footballer Neil Ruddock’s diagnosis and, more recently, stage four diagnosis of Murnaghan, as reported by the Independent. World cup winner Sir Geoff Hurst has also voiced his support for increased screening, advocating for annual or bi-annual tests for men over 45.
Understanding Prostate Cancer & Current Screening Guidelines
prostate cancer is the most common cancer in men in the UK. It develops in the prostate, a small gland that produces fluid for semen. While often slow-growing, it can become aggressive and spread if left undetected.
Currently,there is no national screening program for prostate cancer in the UK. The NHS recommends men over 50, or 45 if they have a family history of the disease or are of African or Caribbean descent, should talk to their doctor about the benefits and risks of Prostate-Specific Antigen (PSA) testing. The PSA test measures the level of PSA in the blood; elevated levels can indicate prostate cancer, but can also be caused by other, less serious conditions.
The Debate Around Mandatory Screening
Sir Geoff Hurst’s call for “mandatory” testing reflects growing frustration with the current system. He told the Press Association that he believes regular testing could save lives by catching the disease earlier. However, mandatory screening is a complex issue with potential drawbacks.
Arguments for mandatory screening:
* Early Detection: Earlier diagnosis generally leads to more effective treatment options and improved survival rates.
* Reduced Mortality: Widespread screening could significantly reduce the number of deaths from prostate cancer.
* Increased Awareness: Mandatory testing would raise public awareness of the disease and encourage men to be more proactive about their health.
Arguments against mandatory screening:
* Overdiagnosis: PSA testing can detect slow-growing cancers that may never cause harm during a man’s lifetime. Treating these cancers unnecessarily (overdiagnosis) can lead to anxiety, side effects from treatment (such as incontinence and erectile dysfunction), and increased healthcare costs.
* False Positives: PSA levels can be elevated for reasons other than cancer, leading to unnecessary biopsies and anxiety.
* Resource Strain: A national screening program would require notable resources, including personnel, equipment, and funding.
Recent Developments and Research
Ongoing research is focused on improving the accuracy of prostate cancer detection and reducing the risks associated with screening. This includes investigating new biomarkers (substances in the body that can indicate disease) and developing more complex imaging techniques.
A large-scale trial, the CAP trial, is currently underway in the UK to assess the effectiveness of a new risk assessment tool combined with MRI scans for prostate cancer screening. Initial results,published in November 2024,suggest this approach could significantly reduce the number of unnecessary biopsies while still detecting aggressive cancers.
Key Takeaways
* Prostate cancer is the most common cancer in men in the UK.
* There is currently no national screening program, but men over 50 (or 45 with risk factors) are advised to discuss testing with their doctor.
* The debate over mandatory screening centers on balancing the benefits of early detection with the risks of overdiagnosis and false positives.
* Ongoing research is focused on improving the accuracy and effectiveness of prostate cancer screening.
It’s crucial for men to be aware of their risk factors,discuss their concerns with their healthcare provider,and make informed decisions about screening based on their individual circumstances.
Worth a look